Impairments in the regulation of central nervous system (CNS) insulin are associated not only with metabolic syndrome and diabetes mellitus but also with Alzheimer’s disease (AD), age-related cognitive decline, and mild cognitive impairment (MCI). Here, INS is linked to Alzheimer disease.